Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Inappropriate ATAC on tamoxifen
Coates A, Mouridsen H, Thürlimann B, BIG 1-98 Collaborative Group. Inappropriate ATAC on tamoxifen. The Lancet 2008; 9:315-6.
Apr 1, 2008Inappropriate ATAC on tamoxifen
Apr 1, 2008The Lancet 2008; 9:315-6
Coates Alan, Mouridsen Henning, Thürlimann Beat, BIG 1-98 Collaborative Group
Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts
von Moos R, Lademann J, Lacouture M, Dummer R, Lorusso D, Scotte F, Sehouli J, Harrold K, Rayson D, Aapro M, Thürlimann B, Hauschild A. Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts. EJO 2008; 44:781-90.
Apr 1, 2008Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts
Apr 1, 2008EJO 2008; 44:781-90
von Moos Roger, Lademann Jürgen, Lacouture Mario E, Dummer Reinhard, Lorusso Domenica, Scotte Florian, Sehouli Jalid, Harrold Karen, Rayson Daniel, Aapro Matti, Thürlimann Beat, Hauschild Axel
Was ist gutes Sterben?
Renz M. Was ist gutes Sterben?. Neue Zürcher Zeitung 2008; 20. März:19.
Mar 20, 2008Was ist gutes Sterben?
Mar 20, 2008Neue Zürcher Zeitung 2008; 20. März:19
Renz Monika
MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome
Wiewrodt D, Nagel G, Dreimüller N, Hundsberger T, Perneczky A, Kaina B. MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome. International journal of cancer. Journal international du cancer 2008; 122:1391-9.
Mar 15, 2008MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome
Mar 15, 2008International journal of cancer. Journal international du cancer 2008; 122:1391-9
Wiewrodt Dorothee, Nagel Georg, Dreimüller Nadine, Hundsberger Thomas, Perneczky Axel, Kaina Bernd
Interdisciplinary tumour boards in Switzerland: quo vadis?
Lehmann K, Gueller U, Bugnon S, Zuber M. Interdisciplinary tumour boards in Switzerland: quo vadis?. Swiss Med Wkly 2008; 138:123-7.
Mar 8, 2008Interdisciplinary tumour boards in Switzerland: quo vadis?
Mar 8, 2008Swiss Med Wkly 2008; 138:123-7
Lehmann Kuno, Gueller Ulrich, Bugnon Sophie, Zuber Markus
Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study
Strasser F, Demmer-Steingruber R, Böhme C, Schmitz S, Thürlimann B, Cerny T, Gillessen Sommer S. Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study. The Oncologist 2008; 13:337-46.
Mar 1, 2008Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study
Mar 1, 2008The Oncologist 2008; 13:337-46
Strasser Florian, Demmer-Steingruber Ruth, Böhme Christel, Schmitz Shu-Fang Hsu, Thürlimann Beat, Cerny Thomas, Gillessen Sommer Silke
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
Kisbenedek L, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof G, Ares L, Pizzocaro G, Mead G, Mason M, Klepp O, Kliesch S, Koehrmann K, Kollmannsberger C, Kuczyk M, Laguna P, Galvis O, Loy V, Pont J, Pottek T, Powles T, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, Skakkebaek N, Sedlmayer F, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz H, Schmidberger H, Schmoll H, Schrader M, von der Maase H, Jones W, Krege S, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder P, De Santis M, de Wit M, de Wit R, Classen J, Cavallin-Ståhl E, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Derigs H, Dieckmann K, Dieing A, Gillessen Sommer S, Hartmann J, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Germa-Lluch J, Gerl A, Droz J, Fenner M, Fizazi K, Flechon A, Fosså S, del Muro X, Gauler T, Geczi L, Joffe J. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. European urology 2008; 53:478-96.
Mar 1, 2008European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
Mar 1, 2008European urology 2008; 53:478-96
Kisbenedek László, Mueller Rolf, Nichols Craig, Nicolai Nicola, Oliver Tim, Ondrus Dalibor, Oosterhof Gosse O N, Ares Luis Paz, Pizzocaro Giorgio, Mead Graham M, Mason Malcolm D, Klepp Olbjørn, Kliesch Sabine, Koehrmann Kai Uwe, Kollmannsberger Christian, Kuczyk Markus, Laguna Pilar, Galvis Oscar Leiva, Loy Volker, Pont Jörg, Pottek Tobias, Powles Tom, Sohaib Aslam, Tjulandin Sergei, Warde Padraig, Weinknecht Stefan, Weissbach Lothar, Wittekind Christian, Winter Eva, Wood Lori, Skakkebaek Niels E, Sedlmayer Felix, Rick Oliver, Rosti Giovanni, Salvioni Roberto, Scheiderbauer Jutta, Schmelz Hans-Ulrich, Schmidberger Heinz, Schmoll Hans-Joachim, Schrader Mark, von der Maase Hans, Jones William G, Krege Susanne, Clemm Christoph, Cohn-Cedermark Gabriella, Culine Stéphane, Daugaard Gedske, De Mulder Pieter H M, De Santis Maria, de Wit Maike, de Wit Ronald, Classen Johannes, Cavallin-Ståhl Eva, Beyer Jörg, Souchon Rainer, Albers Peter, Albrecht Walter, Algaba Ferran, Bamberg Michael, Bodrogi István, Bokemeyer Carsten, Derigs Hans Günter, Dieckmann Klaus-Peter, Dieing Annette, Gillessen Sommer Silke, Hartmann Jörg T, Hartmann Michael, Heidenreich Axel, Hoeltl Wolfgang, Horwich Alan, Huddart Robert, Jewett Michael, Germa-Lluch Jose Ramon, Gerl Arthur, Droz Jean-Pierre, Fenner Martin, Fizazi Karim, Flechon Aude, Fosså Sophie D, del Muro Xavier Garcia, Gauler Thomas, Geczi Lajos, Joffe Johnathan
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
Kisbenedek L, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof G, Paz-Ares L, Pizzocaro G, Mead G, Mason M, Klepp O, Kliesch S, Koehrmann K, Kollmannsberger C, Kuczyk M, Laguna P, Galvis O, Loy V, Pont J, Pottek T, Powles T, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, Skakkebaek N, Sedlmayer F, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz H, Schmidberger H, Schmoll H, Schrader M, von der Maase H, Jones W, Krege S, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder P, De Santis M, de Wit M, de Wit R, Classen J, Cavallin-Ståhl E, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Derigs H, Dieckmann K, Dieing A, Gillessen Sommer S, Hartmann J, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Germa-Lluch J, Gerl A, Droz J, Fenner M, Fizazi K, Flechon A, Fosså S, del Muro X, Gauler T, Geczi L, Joffe J. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. European urology 2008; 53:497-513.
Mar 1, 2008European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
Mar 1, 2008European urology 2008; 53:497-513
Kisbenedek László, Mueller Rolf, Nichols Craig, Nicolai Nicola, Oliver Tim, Ondrus Dalibor, Oosterhof Gosse O N, Paz-Ares Luis, Pizzocaro Giorgio, Mead Graham M, Mason Malcolm D, Klepp Olbjørn, Kliesch Sabine, Koehrmann Kai Uwe, Kollmannsberger Christian, Kuczyk Markus, Laguna Pilar, Galvis Oscar Leiva, Loy Volker, Pont Jörg, Pottek Tobias, Powles Tom, Sohaib Aslam, Tjulandin Sergei, Warde Padraig, Weinknecht Stefan, Weissbach Lothar, Wittekind Christian, Winter Eva, Wood Lori, Skakkebaek Niels E, Sedlmayer Felix, Rick Oliver, Rosti Giovanni, Salvioni Roberto, Scheiderbauer Jutta, Schmelz Hans-Ulrich, Schmidberger Heinz, Schmoll Hans-Joachim, Schrader Mark, von der Maase Hans, Jones William G, Krege Susanne, Clemm Christoph, Cohn-Cedermark Gabriella, Culine Stéphane, Daugaard Gedske, De Mulder Pieter H M, De Santis Maria, de Wit Maike, de Wit Ronald, Classen Johannes, Cavallin-Ståhl Eva, Beyer Jörg, Souchon Rainer, Albers Peter, Albrecht Walter, Algaba Ferran, Bamberg Michael, Bodrogi István, Bokemeyer Carsten, Derigs Hans Günter, Dieckmann Klaus-Peter, Dieing Annette, Gillessen Sommer Silke, Hartmann Jörg T, Hartmann Michael, Heidenreich Axel, Hoeltl Wolfgang, Horwich Alan, Huddart Robert, Jewett Michael, Germa-Lluch Jose Ramon, Gerl Arthur, Droz Jean-Pierre, Fenner Martin, Fizazi Karim, Flechon Aude, Fosså Sophie D, del Muro Xavier Garcia, Gauler Thomas, Geczi Lajos, Joffe Johnathan
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Aapro M, Saad F, Rizzoli R, Paterson A, Monnier A, Lipton A, Jonat W, Hortobagyi G, Hadji P, Gralow J, Gnant M, Dirix L, Crinò L, Costa L, Colomer R, Coleman R, Body J, Abrahamsson P, Thürlimann B. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol 2008; 19:420-32.
Mar 1, 2008Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Mar 1, 2008Ann Oncol 2008; 19:420-32
Aapro M, Saad F, Rizzoli R, Paterson A H G, Monnier A, Lipton A, Jonat W, Hortobagyi G N, Hadji P, Gralow J, Gnant M, Dirix L, Crinò L, Costa L, Colomer R, Coleman R E, Body J J, Abrahamsson P A, Thürlimann Beat
Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma
Früh M, Christiani D, Shepherd F, Lynch T, Nishioka N, Wain J, Heist R, Su L, Zhai R, Zhou W, Liu G. Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. British journal of cancer 2008; 98:689-92.
Feb 26, 2008Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma
Feb 26, 2008British journal of cancer 2008; 98:689-92
Früh Martin, Christiani D C, Shepherd F A, Lynch T J, Nishioka N S, Wain J C, Heist R S, Su L, Zhai R, Zhou W, Liu G
Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study
Langer I, Zuber M, Burger D, Infanger E, Uehlinger U, Wight E, Schnarwyler B, Bronz L, Oertli D, Hess T, Fehr M, Schaer G, Moch H, Koechli O, Berclaz G, Gueller U, Swiss Multicenter Study Group Sentinel Lymph Node in Breast Cancer. Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Res Treat 2008; 113:129-36.
Feb 23, 2008Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study
Feb 23, 2008Breast Cancer Res Treat 2008; 113:129-36
Langer Igor, Zuber Markus, Burger Daniel, Infanger Eduard, Uehlinger Urs, Wight Edward, Schnarwyler Beate, Bronz Lucio, Oertli Daniel, Hess Thomas, Fehr Mathias K, Schaer Gabriel, Moch Holger, Koechli Ossi R, Berclaz Gilles, Gueller Ulrich, Swiss Multicenter Study Group Sentinel Lymph Node in Breast Cancer
Dermatologische Nebenwirkungen der EGFR-Inhibitoren
Haug S, Anliker M, Köberle D. Dermatologische Nebenwirkungen der EGFR-Inhibitoren. TMJ 2008; 2008:7-11.
Feb 16, 2008Dermatologische Nebenwirkungen der EGFR-Inhibitoren
Feb 16, 2008TMJ 2008; 2008:7-11
Haug Suanne, Anliker Mark, Köberle Dieter
Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits
Busse A, Kraus M, Na I, Rietz A, Scheibenbogen C, Driessen C, Blau I, Thiel E, Keilholz U. Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits. Cancer 2008; 112:659-70.
Feb 1, 2008Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits
Feb 1, 2008Cancer 2008; 112:659-70
Busse Antonia, Kraus Marianne, Na Il-Kang, Rietz Anika, Scheibenbogen Carmen, Driessen Christoph, Blau Igor Wolfgang, Thiel Eckhard, Keilholz Ulrich
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study
von Minckwitz G, Kaufmann M, Mehta K, Loibl S, Skacel T, Vescia S, Grasshoff S, Jackisch C, Costa S, Huober J, Hilfrich J, Gerber B, Eidtmann H, Eiermann W, du Bois A, Kümmel S, German Breast Group. Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:292-8.
Feb 1, 2008Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study
Feb 1, 2008Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:292-8
von Minckwitz G, Kaufmann M, Mehta K M, Loibl S, Skacel T, Vescia S, Grasshoff S-T, Jackisch C, Costa S D, Huober Jens, Hilfrich J, Gerber B, Eidtmann H, Eiermann W, du Bois A, Kümmel S, German Breast Group
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
Strasser F, Cerny T, Von Moss R, Brändle M, Holst B, Kaufmann K, Tschöp M, Büche D, Thürlimann B, Maeder M, Lutz T, Demmer-Steingruber R. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. BJC 2008; 98:300-8.
Jan 29, 2008Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
Jan 29, 2008BJC 2008; 98:300-8
Strasser Florian, Cerny Thomas, Von Moss Roger, Brändle Michael, Holst B, Kaufmann K, Tschöp M, Büche Daniel, Thürlimann Beat, Maeder Micha, Lutz T A, Demmer-Steingruber Ruth
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
Bernhard J, Coates A, Goldhirsch A, Price K, Castiglione-Gertsch M, Gelber R, Colleoni M, Green M, Thürlimann B, Yeo W, Aebi S, Forbes J, Hürny C, Basser R, Martinelli G, Zhang J, Zahrieh D, International Breast Cancer Study Group. Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. BJC 2008; 98:25-33.
Jan 15, 2008Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
Jan 15, 2008BJC 2008; 98:25-33
Bernhard J, Coates A S, Goldhirsch A, Price K N, Castiglione-Gertsch M, Gelber R D, Colleoni M, Green M D, Thürlimann Beat, Yeo W, Aebi S, Forbes J F, Hürny C, Basser R, Martinelli G, Zhang J J, Zahrieh D, International Breast Cancer Study Group
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
Schulz H, Engert A, Diehl V, Schnell R, Borchmann P, Rüdiger T, Driessen C, Elter T, Morschhauser F, Rehwald U, Reiser M. Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). Blood 2008; 111:109-11.
Jan 1, 2008Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
Jan 1, 2008Blood 2008; 111:109-11
Schulz Holger, Engert Andreas, Diehl Volker, Schnell Roland, Borchmann Peter, Rüdiger Thomas, Driessen Christoph, Elter Thomas, Morschhauser Franck, Rehwald Ute, Reiser Marcel
Side Effects of Drugs Annual 30
Jörger M, Hartmann K, Kuhn M. Side Effects of Drugs Annual 30 - Drugs acting on the respiratory tract. In: Side Effects of Drugs Annual 30. Oxford UK: Elsevier; Linacre House Jordan Hill, 2008. ISBN 0-444-52767-2.
Jan 1, 2008Side Effects of Drugs Annual 30
Jan 1, 2008Elsevier; Linacre House Jordan Hill, ISBN 0-444-52767-2
Jörger Markus, Hartmann K, Kuhn M
Erlösung aus Prägung
Renz M. Erlösung aus Prägung - Botschaft und Leben Jesu als Überwindung der menschlichen Angst-, Begehrens- und Machtstruktur. Paderborn: Junfermann, 2008. ISBN 978-3873877085.
Jan 1, 2008Erlösung aus Prägung
Jan 1, 2008Junfermann, ISBN 978-3873877085
Renz Monika
Zeugnisse Sterbender
Renz M. Zeugnisse Sterbender - Todesnähe als Wandlung und letzte Reifung. Paderborn: Junfermann, 2008. ISBN 978-3873877122.
Jan 1, 2008Zeugnisse Sterbender
Jan 1, 2008Junfermann, ISBN 978-3873877122
Renz Monika